Table 3.
BMAL1 | p -value of acrophase | ||||
---|---|---|---|---|---|
Group | Acrophase (estimates ± SE) | Peak time (h) | Sham vs. 6-OHDA | 6-OHDA vs. 6-OHDA+L-dopa | Sham vs. 6-OHDA+L-dopa |
Sham | 2.8036 ± 0.5333 | 10.7 | 0.3442 | 0.0834 | 0.4947 |
6-OHDA | 2.0881 ± 0.5207 | 8.0 | |||
6-OHDA+L-dopa | 3.2535 ± 0.3823 | 12.4 | |||
CLOCK | p -value of acrophase | ||||
Group | Acrophase (estimates ± SE) | Peak time (h) | Sham vs. 6-OHDA | 6-OHDA vs. 6-OHDA+L-dopa | Sham vs. 6-OHDA+L-dopa |
Sham | 2.4799 ± 0.2111 | 9.5 | 0.4949 | 0.1016 | 0.1344 |
6-OHDA | 2.1530 ± 0.4446 | 8.2 | |||
6-OHDA+L-dopa | 3.5475 ± 0.7178 | 13.6 |
L-dopa, L-3,4-dihydroxyphenylalanine.